Paraoxonase‐1 Gene Haplotypes Are Associated with Metabolic Disturbances, Atherosclerosis, and Immunologic Outcome in HIV‐Infected Patients
Open Access
- 15 February 2010
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 201 (4) , 627-634
Abstract
Background. Oxidative stress is associated with human immunodeficiency virus (HIV) infection. Paraoxonase-1 (PON1) is an antioxidant enzyme that is bKeywords
This publication has 24 references indexed in Scilit:
- The paraoxonases: role in human diseases and methodological difficulties in measurementCritical Reviews in Clinical Laboratory Sciences, 2009
- The measurement of the lactonase activity of paraoxonase-1 in the clinical evaluation of patients with chronic liver impairmentClinical Biochemistry, 2009
- Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissuesFree Radical Biology and Medicine, 2008
- Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infectionAtherosclerosis, 2007
- Diet and lifestyle are associated with serum C-reactive protein concentrations in a population-based studyJournal of Laboratory and Clinical Medicine, 2005
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- Four paraoxonase gene polymorphisms in 11 212 cases of coronary heart disease and 12 786 controls: meta-analysis of 43 studiesThe Lancet, 2004
- A New Statistical Method for Haplotype Reconstruction from Population DataThe American Journal of Human Genetics, 2001
- Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidantsFree Radical Biology and Medicine, 1999
- Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modificationFEBS Letters, 1998